Lupin's Brivaracetam Oral Solution approved by US FDA

Johnson & Johnson submits sBLA to FDA for first-ever treatment for wAIHA

AlzeCure's ACD440 granted EU orphan drug status for erythromelalgia

Armata Pharmaceuticals' AP-SA02 receives QIDP designation from US FDA

Immedica Pharma's Loargys (pegzilarginase-nbln) receives accelerated US FDA approval

Gossamer Bio reports topline Phase 3 PROSERA results for seralutinib in PAH

Organon licenses MIUDELLA IUD from Sebela Pharmaceuticals

Gilead to acquire Arcellx to gain full control of anito-cel

Novo Nordisk's CagriSema achieves 23% weight loss but misses primary endpoint in REDEFINE 4 trial

AbbVie's VENCLEXTA (venetoclax) and acalabrutinib combination receives US FDA approval to treat CLL

Vanda Pharmaceuticals' BYSANTI (milsaperidone) tablets receive US FDA approval

FDA accepts Genentech application for giredestrant combination in ESR1-mutated advanced breast cancer

FDA approves Genentech oral Venclexta plus AstraZeneca's Calquence combination for first-line CLL

EMA validates Enhertu application for post-neoadjuvant HER2-positive early breast cancer

Merck reports positive Phase 3 data for Enflonsia in high-risk children across two RSV seasons